Are Your Lung Cancer ICD 10 Codes Specific Enough? The Laterality, Histology, and Staging Details Payers Review
Learn how Lung Cancer ICD 10 laterality, histology, and staging details affect coding accuracy, medical necessity, and payer reviews to prevent costly claim denials.

When billing oncology, it is essential to use accurate coding for diagnosis. The Lung Cancer ICD 10 will impact claim submission, medical necessity evaluations, treatment authorizations, and reimbursement. If it’s not coded correctly or there’s a lack of laterality, there are coding inaccuracies that could lead to denials.
C34 is the leading ICD-10-CM diagnosis for malignant neoplasms of the bronchus and lung. But, C34 is a non-billable category. The coder should take the conditions of documentation indicating the anatomical location and laterality into account, and necessarily choose a more specific code for the record.
During Lung Cancer Awareness Month, oncology practices also have an opportunity to review how accurate diagnosis reporting supports cancer care. From a medical billing perspective, complete documentation helps connect the patient’s confirmed diagnosis with treatment services, authorization requirements, and payer reimbursement policies.
Knowing Lung Cancer ICD 10 can help improve oncology billing teams to tell primary malignancies from metastatic disease. It also enables them to report active cancer accurately, and not incorrectly use personal history codes.
This guide describes the codes, documentation, coding and billing tips and pointers that are relevant to oncology practices.
What Is the Lung Cancer ICD 10 Code?
The primary Lung Cancer ICD 10 code is C34 Malignant neoplasm of bronchus and lung. The correct code will vary based on the identified site of the tumor and for most tumor sites, the side of the tumor.
It is important that a diagnosis be made by the coder and not just the general term “lung cancer”. If the provider has documented it then the medical record should reflect the affected bronchus or lung lobe. The information will influence the Lung Cancer ICD 10 code the billing team will report.
| ICD-10-CM code | Description |
|---|---|
| C34.0 | Malignant neoplasm of main bronchus |
| C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
| C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
| C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
C34.2 is a full code code. Other entries in this table are level-of-category codes; two or more characters are needed to specify the site or laterality.
Lung Cancer ICD 10 Codes by Anatomical Location
To properly assign the correct Lung Cancer ICD 10 code, it’s important to review the provider’s documented tumor location. The following code groups will help differentiate the main bronchus, individual lobes, overlapping locations and unspecified locations. The anatomic site reported in the ICD 10 codes must match the reported site.
1. Main Bronchus Cancer Codes
Each bronchus leads from the trachea into the lung. Documentation should indicate if the malignancy has invaded into the right or left principal bronchus.
| ICD-10-CM code | Description |
|---|---|
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
Documented right main bronchus malignancy report with C34.01 and the left with C34.02. If there is no documentation of laterality, choose C34.00.
2. Upper Lobe Lung Cancer Codes
The code for malignant conditions in the upper lobe (zone) needs to specify which side is affected. Medical records should indicate the right or left upper lobe if there is a tumor.
| ICD-10-CM code | Description |
|---|---|
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
If, for instance, a tumor has been documented in the right upper lobe, then Lung Cancer ICD 10 C34.11 is used. A right/left coding isn’t justified by a single record that documents the diagnosis of upper lobe cancer.
3. Middle Lobe Lung Cancer Codes
In the right lung, the middle lobe is there. It is a code which applies to a malignant neoplasm (no laterality character is required in this instance).
| ICD-10-CM code | Description |
|---|---|
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
C34.2 is a complete billable code. Do not create an additional right-sided or left-sided variation.
4. Lower Lobe Lung Cancer Codes
Lower lobe malignancies require documentation of the affected side when available.
| ICD-10-CM code | Description |
|---|---|
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
C34.31 is a modifier to include a documented right lower lobe malignancy. When the lower lobe is described without specifying laterality, the specificity available in the record is designated by C34.30. This distinction helps avoid reporting errors while listing Lung Cancer ICD 10.
5. Overlapping Sites of Bronchus and Lung
Two overlapping lesions are contiguous (two locations are next to each other); no point of origin is found. This classification must be supported by the provider’s documentation.
| ICD-10-CM code | Description |
|---|---|
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
A tumor that extends into another location should not lead to the use of an overlapping-site code so long as the site has appeared in other codes. When classification rules support it, code primary site if documentation indicates the sites if not, classify the patient’s site.
6. Unspecified Part of Bronchus or Lung
In some cases it is found on the medical record that the disease is malignant, but there is no mention of which lobe or bronchus the tumour is in. Laterality is available in some cases: the unspecified code is used in these cases.
| ICD-10-CM code | Description |
|---|---|
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
If no specific location or no side are recorded use C34.90. If this record states that the side is indicated but the exact site is not given, then choose the appropriate right or left code. Refer to pathology notes, imaging interpretation, oncology notes and operative documentation prior to assigning an unspecified code. Ask questions for full understanding.
How Laterality Affects Lung Cancer ICD 10 Coding
Laterality indicates right/side or left-side malignancy or no laterality. The detail is needed for several C34 code groups for accurate reporting. For instance, there are different options for the right and left lobes, as well as an unspecified option for the upper and lower lobes. There is the same situation in the main bronchus and overlapping-site groups. Malignancy of the middle lobe is coded C34.2 with no laterality described.
| Documentation | Appropriate code |
|---|---|
| Right main bronchus malignancy | C34.01 |
| Left main bronchus malignancy | C34.02 |
| Right upper lobe malignancy | C34.11 |
| Left upper lobe malignancy | C34.12 |
| Middle lobe malignancy | C34.2 |
| Right lower lobe malignancy | C34.31 |
| Left lower lobe malignancy | C34.32 |
One of the regular billing issues that arise is when one of the sides in the code submitted does not correspond to the documented side. For instance, if a tumor of the right upper lobe is submitted with C34.12, the documentation mismatch results.
Your coding team should verify the diagnosis with the provider’s documentation and other available documents. A review confirms that the side in the Lung Cancer ICD 10 code is correct. Never use the word ‘lateral’ in isolation in an imaging report, unless it follows the correct coding rules.
Clinical Terms That Affect Lung Cancer ICD 10 Selection
Histology, the behaviour of the tumour and the classification of the disease are recorded in oncology. The following terms may be used to describe the malignancy, but do not automatically imply the anatomical code.
Non-Small Cell Lung Cancer
There are several histological types of non-small cell lung cancer (NSCLC), such as adenocarcinoma and squamous cell carcinoma. The classification of a cancer is supported by the report of the history and the anatomical location of the cancer will identify which C34 code to use. CPC’s should be aware of this distinction when coding for Lung Cancer ICD 10 Code.
Adenocarcinoma left upper lobe, for example, is supported by C34.12, and is documented to be in the left upper lobe. Always do not choose an alternative site code because there is a pathological diagnosis of adenocarcinoma.
Small Cell Lung Cancer
It is important to remember that there is a distinct type of cancer, small cell lung cancer (SCLC). The pathology report will specify the type of cancer and the provider’s notes would define the main site of the cancer being treated. The documented location of small cell carcinoma when documented in the right main bronchus will be recorded in C34.01.
Adenocarcinoma and Squamous Cell Carcinoma
Common terms used to describe the type of cancer in the lungs are adenocarcinoma and squamous cell carcinoma. These terms are often mentioned in conjunction with the location of the tumor and other findings in the report of the path. The provider’s diagnosis should be confirmed by coders to mean that the diagnosis is for malignancy and the anatomical site. Histology doesn’t dictate the lobe or the side of involvement.
Bronchogenic Carcinoma
Bronchogenic Carcinoma is a cancer that develops on the tissue of the bronchus or lung. This word does not indicate individual lobe or side. Before selecting a site-specific code, please read the documentation and review the oncology assessment. If the record doesn’t specify any anatomy, use the generic anatomy options or ask for clarification.
Metastatic Lung Cancer
It’s important to review the term “metastatic lung cancer. It can refer to cancer which began in the lung and then spread to another place in the body, or cancer that was present in another organ and has then spread in the lungs.
Codes and diagnoses will vary for these situations. The primary lung malignancy is usually classified under C34 and the secondary malignant neoplasm of the lung is classified under C78.0. Correct Reporting of Lung Cancer ICD 10 relies on diagnosis of the place of origin of the cancer.
Primary vs. Secondary Lung Cancer Coding
An important difference for Lung Cancer ICD 10 is whether the cancer is in the lung (origin) or if the lung is a site of metastasis. Primary lung cancer is a starting tumor in the bronchus or the lung tissue. Secondary lung cancer occurs when the cancer has travelled to the lung from another primary cancer.
Primary Malignant Neoplasm of the Lung
Utilize the correct C34 code when a primary malignant tumor in the bronchus/lung is provided. The selected code should show the location and laterality as described. For instance, if your cancer is primarily of the right lower lobe, it can be supported by C34.31. A separate malignancy code for the liver may also be found on the record should the malignancy spread to the liver.
Secondary Malignant Neoplasm of the Lung
For secondary malignant neoplasm of the lung use C78.0. The documentation side used determines the code to be selected.
| ICD-10-CM code | Description |
|---|---|
| C78.00 | Secondary malignant neoplasm of unspecified lung |
| C78.01 | Secondary malignant neoplasm of right lung |
| C78.02 | Secondary malignant neoplasm of left lung |
For instance, if a patient has been diagnosed with primary breast cancer then has documented metastases to the right lung, then the C78.01 should be used for the right lung metastasis and not the breast cancer diagnosis. When assigning a C34 code, note that Primary lung malignancy must also be documented separately.
How Sequencing Affects Oncology Claims
The order of diagnosis depends upon the purpose of the encounter and the treatments rendered. Official coding guidelines have been developed and outline the sequence of primary and secondary malignancies.
- If there is a primary malignancy to be treated, then follow the sequence of the primary cancer followed by any appropriate metastatic sites.
- If only a secondary location is being treated, then the metastatic location is the subject of the treatment report, and the primary malignancy should be mentioned as an additional diagnosis.
- If the encounter is only going to be on a complication, use the appropriate sequent instructions for that complication.
So, a patient with a diagnosed primary lung cancer with known osseous metastases will typically have the lung cancer sequenced first, when the treatment targets the lung cancer. If it is a bone metastasis, you can have the primary site listed as the first listed diagnosis.
Active Lung Cancer vs. Personal History of Lung Cancer
Active malignancy versus personal history has an impact on Lung Cancer ICD 10 reporting. The appropriate code will depend on whether the cancer has shown signs of recurrence or there is still treatment going on at the primary site. This status directly impacts on Lung Cancer ICD 10 selection.
When to Use an Active Malignancy Code
If the patient has an active primary lung malignancy, continue to follow the appropriate C34 code. The code is also still valid and suitable when following surgery (like chemotherapy or radiation) is directed at the resected area.
For instance a patient having undergone lung surgery but still receiving treatment for the primary disease is not eligible for a personal history code.
When to Use Z85.118
Z85.118 is a personal history of bronchus and lung for other malignant neoplasms. It is used in cases of complete surgical removal or eradication of the primary malignancy, when no other cancer treatment is required in the same area of the body, and when no signs of the primary malignancy is found upon examination.
| Patient situation | Coding direction |
|---|---|
| Active primary lung cancer | Appropriate C34 code |
| Tumor removed, but treatment continues at the primary site | Appropriate C34 code |
| Primary malignancy eradicated, treatment completed, no remaining disease at that site | Z85.118, when applicable |
| Former primary lung cancer with current metastasis elsewhere | Code the secondary malignancy and applicable history code |
Do not use Z85.118 as a replacement for an active malignancy code when the patient has had surgery. Before changing the diagnosis, check the treatment plan and what documentation there is.
Documentation Requirements for Lung Cancer ICD 10
Flaws in Lung Cancer ICD 10 reporting begin with incomplete and inconsistent clinical documentation. Medical records need to be prepared so that the oncology team can have a solid medical record, in support of the code chosen before the claim is submitted. Full documentation ensures enhanced accuracy of Lung Cancer ICD 10 coding and aids in payer review.
| Documentation element | Why it matters |
|---|---|
| Confirmed malignancy diagnosis | Establishes the condition being coded |
| Primary or secondary status | Separates original cancer from metastatic disease |
| Anatomical location | Identifies the bronchus or lung lobe |
| Laterality | Supports right, left, or unspecified code selection |
| Histology and pathology findings | Support the documented cancer type |
| Metastatic sites | Support additional secondary malignancy codes |
| Current treatment status | Distinguishes active malignancy from personal history |
| Provider assessment and plan | Connects the diagnosis with the services performed |
Review Pathology and Imaging Documentation
Pathology reports can contribute to the diagnosis of the type of tumour found and the findings regarding malignancy. Imaging reports frequently mention specific side, lobe and possible spread. Documentation and coding should abide by those rules, coders should follow these rules when using these records. Do not assume a provider has made a diagnosis, when provider confirmation is required, based on a radiology finding.
Confirm the Provider’s Diagnosis
The oncology assessment should definitively report the primary lung cancer, metastatic disease or a history of cancer. Coding uncertainty when there is conflict describing notes. The cancer cells should not be recorded with left upper lobe cancer in one using system and right upper lobe cancer in another. A provider query assists with making sure you claim the correct diagnosis before it gets sent to insurers.
Check Treatment Status
Treatment records should record whether the patient is receiving active treatment for cancer or routine follow up after the end of treatment. This distinction affects the selection between C34 and Z85.118. Never use an older problem list entry to determine present cancer status. Review the latest oncology assessment and treatment plan.
Lung Cancer Coding Across Different Clinical Settings
Patients’ care related to cancer occurs across multiple departments. There are different documentation and billing requirements for each setting even with the same diagnosis. These encounters should be treated in the same way for teams, using the Lung Cancer ICD 10 rules.
Oncology Clinics
A medical oncologist directs chemotherapy or immunotherapy courses, develops course plans and records chemotherapy or immunoglobulin encounters. The billing team should correlate between diagnosis and treatment given and provider’s diagnosis.
Pulmonology Practices
A pulmonologist explores the lung abnormalities, conducts tests to diagnose the issue and treats respiratory problems. Attached documentation can include bronchoscopy results, biopsy information and a possible malignancy. If the diagnosis has been elusive, coders are also required to use the appropriate inpatient or outpatient rule. Only use a suspected diagnosis as a confirmed diagnosis when in an outpatient setting.
Inpatient Hospital Services
In hospital coding, the selection of the principal diagnosis is crucial to accuracy, as is the proper coding of all other diagnoses. There are different reasons for admitting the child to hospital and different priorities for the treatment that should affect the sequence of treatments, and there is some evidence to suggest the status of the child in terms of a known malignancy.
An admission for treatment of a primary lung tumour is different from one which is focused on treating a complication or metastatic site.
Radiation Oncology
The cancer site and treatment target should be noted on the radiation oncology records. The diagnosis should be evaluated with the radiation service and appropriate medical necessity criteria.
Infusion Centers
Supportive medications, chemotherapy and immunotherapy are given at infusion centers. The claim should be a representation of the condition that is being treated, and the specific services documented for the encounter. Coverage is not guaranteed by the diagnosis. A treatment plan, information about the drugs, drug administration log, etc. may be needed as well.
Surgical Oncology
Medical records for surgical oncology will contain details of the site location, the identification of the cancer with the surgery, the pathological analysis, and the treatment plan after surgery. Billing staff should check these records to verify the proper site, and proper current Malaignancy status.
CPT Codes Commonly Associated With Lung Cancer Services
The ICD-10-CM diagnosis codes give a diagnosis for the patient. CPT codes refer to the procedure/services provided at the encounter. Diagnostic imaging, bronchoscopy, biopsy, administration of radiation and chemotherapy would be covered. This is an example of the many CPT codes available, and it fluctuates with the service, technique, documentation and coding rules. There should also be an Lung Cancer ICD 10 diagnosis, which should be consistent with the reason for the service.
| CPT code | Service description |
|---|---|
| 32408 | Core needle biopsy of lung or mediastinum, percutaneous |
| 31622 | Diagnostic bronchoscopy |
| 31625 | Bronchoscopy with biopsy |
| 71250 | CT scan of thorax without contrast |
| 71260 | CT scan of thorax with contrast |
| 71270 | CT scan of thorax without contrast, followed by contrast and further sections |
| 77301 | Intensity-modulated radiation therapy treatment planning |
| 96413 | Chemotherapy administration, intravenous infusion technique, up to one hour |
| 96415 | Each additional hour of chemotherapy infusion |
The codes are illustrative of services related to Lung Cancer care. They do not necessarily have to be paid whenever a C34 diagnosis is given. A case in point is a person needing diagnostic bronchoscopy could have a malignancy diagnosis that’s being considered. A claim should adhere to the documented procedure and adherence to the diagnosis reporting requirements.
The administration of chemotherapy codes must document the following information about the chemotherapy: The drug type, how it was administered, duration, and other factors that apply. When claiming, refer to and confirm current CPT coding guidelines, coding changes and coding policies to payers.
Medical Necessity Requirements for Lung Cancer Claims
You cannot guarantee reimbursement based on a correct diagnosis code. Payers also assess if the billed service is covered and considers it to be medically necessary. The diagnosis needs to match the type of service. Clinical documentation should clarify why the patient required the procedure, imaging study, radiation therapy or medication.
Imaging and Diagnostic Procedures
Documentation is required to accompany the examination or procedure for CT, biopsies and bronchoscopy services. A record should link the patient’s clinical findings to the services ordered. A CT scan to assess a “Suspect lung lesion” must be backed by supporting clinical information. A diagnosis of malignancy alone is not a substitute for documentation of service-specific diagnoses.
Chemotherapy and Immunotherapy
Specific records of the treatment plan and what the medication is given will be required for drug administration claims. Billing teams should check the diagnosis, drug code, administration code, dosage, and payer requirements. Administrative records and incomplete treatment records create reimbursement issues. The medical record should be used as evidence for the services reported on the claim.
Radiation Therapy
Radiation claims would require documentation pertaining to the treatment site, prescribed course, planning services, and delivered treatment. The diagnosis should correspond with the condition and site being treated. Additionally, billing teams should also check authorization requirements and policies of various payers prior to filing claims for radiation therapy services.
Common Lung Cancer Coding Errors That Cause Denials
Common errors that occur in the selection of Lung Cancer ICD 10 tend to start with the lack of documentation of cancer status or an incorrect determination of cancer status. Inconsistencies in the coding of the diagnoses affects billing without it being necessary since some codes do not match up with the clinical records. Lung Cancer ICD 10 information is reviewed prior to submitting to prevent these problems.
| Common error | Potential claim impact | Recommended correction |
|---|---|---|
| Reporting C34 instead of a specific code | Invalid or incomplete diagnosis reporting | Select the appropriate reportable code |
| Missing laterality | Reduced diagnosis specificity | Confirm the documented side |
| Confusing primary and secondary cancer | Incorrect diagnosis classification | Verify the original cancer site |
| Using an active cancer code after completed treatment | Incorrect current disease status | Review treatment completion and documentation |
| Reporting a history code during active treatment | Incorrect diagnosis reporting | Confirm whether treatment targets the original site |
| Using an overlapping-site code incorrectly | Unsupported anatomical classification | Confirm the tumor’s point of origin |
| Missing metastatic-site documentation | Incomplete secondary diagnosis reporting | Review oncology and imaging records |
| Diagnosis does not support the billed service | Medical necessity concerns | Connect the diagnosis with the service performed |
Practical Lung Cancer Coding and Billing Scenarios
A series of scenarios to illustrate how the various requirements of Lung Cancer ICD 10 apply to different oncology encounters.
Scenario 1: Right Upper Lobe Primary Lung Cancer
Oncologist records primary lung cancer in the right upper lobe. The pathological report is conclusive for malignancy and the patient is given treatment.
The last diagnosis is C34.11. Billing staff should ensure assessment is in line with location and services documented in treatment documentation to support services billed.
Scenario 2: Cancer From Another Organ Spreads to the Lung
A breast cancer patient gets a documented secondary malignancy in the left lung. The provider confirms that the lesion is from metastatic breast cancer.
Finding jaw pain, mouth pain, or pain of the neck and mouth is coded as C78.02, appropriate secondary finding, pain of mouth. A primary lung cancer code should not be used without precise documentation of a primary lung cancer diagnosis.
How Billing Care Solutions Supports Oncology RCM
Oncology Billing is a complex process with complexities in diagnosis selection, documentation of treatment facts, Payer’s requirement and claim follow-up. Billing teams need to find proper coordination with these aspects to avoid preventable denials and to ensure reimbursements. Billing Care Solutions is a provider of healthcare solutions that include medical coding, medical billing, claim scrubbing, denial management, and accounts receivable services.
The company compares diagnosis and procedure information with available documentation to detect missing laterality, primary and secondary malignancy labeling and unnecessary diagnosis choices. It also has a powerful claim scrubbing function, which can highlight inconsistencies in the coding of a claim and errors, thereby creating a chance for internal billers to prevent these issues from reaching the claims provider.
Billing Care Solutions also assists in denial management by reviewing claim issues, monitoring supporting records and arranging activities that need to follow up with the claim. Bill Coordination is offered via a dedicated account manager, giving practices a single point of contact for billing; Daily Financial Reports allow practices to track the activity on claims and the performance of the finances of their claim.
Billing Care Solutions assists small to large healthcare practices by handling billing processes, alleviating administrative burdens, and simplifying the entire procedure with its USA based support team. Practices considering an RCM partner should look into coding accuracy, denial management, reporting and communication practices. Billing Care Solutions will provide a complimentary consultation to review billing issues and ways to improve operations.
Final Thoughts on Lung Cancer ICD 10 Coding
Only choosing C34 is not enough to ensure correct Lung Cancer ICD 10 coding. The coding team needs to check anatomical location, left or right, primary and secondary status, as well as current treatment status. The information has an impact on diagnosing reporting, claim accuracy, medical necessity reviews and reimbursement. When documentation is incomplete, or the code isn’t the most appropriate, these issues cause needless delays in oncology practices.
Review all ICD-10-CM guidelines; verify provider documentation and flow and review any payer-specific requirements before claims are submitted. Having a consistent coding and claim review process in your practice can save you a ton of preventable billing mistakes, as well as keeping your practice cleaner revenue cycle operations. Correct Lung Cancer ICD 10 coding continues to be a significant step in that direction.

